Cargando…
Crispr Library Screening: Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma (Adv. Sci. 17/2019)
In article number 1900782, Xudong Wu, Tao Jiang, and Chunsheng Kang, and co‐workers present a genome‐wide screening under a clustered regularly interspaced short palindromic repeats (CRISPR)‐Cas9 library. Notably, E2F6 was proven to drive the temozolomide (TMZ) resistance of 191 glioblastoma‐related...
Autores principales: | Huang, Kai, Liu, Xing, Li, Yansheng, Wang, Qixue, Zhou, Junhu, Wang, Yunfei, Dong, Feng, Yang, Chao, Sun, Zhiyan, Fang, Chuan, Liu, Chaoyong, Tan, Yanli, Wu, Xudong, Jiang, Tao, Kang, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724468/ http://dx.doi.org/10.1002/advs.201970103 |
Ejemplares similares
-
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
por: Huang, Kai, et al.
Publicado: (2019) -
Fish Capsules: A System for High‐Throughput Screening of Combinatorial Drugs (Adv. Sci. 9/2022)
por: Tang, Minghui, et al.
Publicado: (2022) -
The NO Answer for Autism Spectrum Disorder (Adv. Sci. 22/2023)
por: Tripathi, Manish Kumar, et al.
Publicado: (2023) -
Designing Magnetism in High Entropy Oxides (Adv. Sci. 10/2022)
por: Mazza, Alessandro R., et al.
Publicado: (2022) -
Metasurface‐Programmable Wireless Network‐On‐Chip (Adv. Sci. 26/2022)
por: Imani, Mohammadreza F., et al.
Publicado: (2022)